Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amlodipine + delapril is a fixed-dose combination of two antihypertensive agents used to treat high blood pressure. Amlodipine is a long-acting dihydropyridine calcium channel blocker that lowers blood pressure by inhibiting voltage-dependent L-type calcium channel in vascular smooth muscle, leading to vasodilation and reduced peripheral resistance[1][2][3]. Delapril is an angiotensin-converting enzyme (ACE) inhibitor that reduces the formation of angiotensin II, resulting in decreased vasoconstriction and aldosterone-mediated sodium retention[6][8]. The combination provides complementary mechanisms for blood pressure reduction and may be used when monotherapy with either agent is insufficient.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amlodipine + delapril.